The stock market rallied impressively since the third quarter of 2023. In January, although it experienced a downturn, key market indices such as the S&P500 and Nasdaq have been on an upward trajectory, building on the significant gains of the previous year. This rally has resulted in a rapid escalation in the valuations of various stocks. However, without prudent caution, investors risk substantial portfolio devaluation due to companies with exorbitant multiples. Here are three overvalued stocks to sell, taking pre-emptive action before investors potentially suffer significant losses.

Questionable Valuation of Arm Holdings (ARM)

Source: Ascannio / Shutterstock.com

The semiconductor chip designer Arm Holdings (NASDAQ:ARM) captured the spotlight toward the end of August 2023 as it readied itself for its public market debut. Ultimately, ARM successfully raised close to $5 billion from the public markets. Following a 25% surge on its first day of trading, the chip stock boasted a valuation of approximately $60 billion.

For the uninitiated, this semiconductor company already possesses the intellectual property that forms the backbone of the software and architecture for developing systems-on-a-chip (SoCs) for smartphones, tablets, and Internet of Things (IoT) devices. Furthermore, Arm’s leadership aims to realign the company to assume a pivotal role in AI chip technology. For example, the chip designer has played a substantial role in the development of Nvidia’s Grace Hopper Superchip, fusing Arm’s Neoverse processor cores with Nvidia’s H100 Tensor Core GPU for achieving unparalleled performance levels.

Investors in ARM witnessed an appreciation of over 18% in their holdings by the end of 2023, and since the commencement of trading in 2024, the chip designer’s stock price has surged by almost 60%. However, the predicament lies in ARM being significantly overvalued. Currently, shares are being traded at an astronomical 90.7x forward earnings, nearly double its earnings per share. Regrettably, such stocks are ripe for a major selloff, especially if the macroeconomic climate fails to stabilize as swiftly as predicted.

Overinflated Position of Manhattan Associates (MANH)

Manhattan Associates (NASDAQ:MANH) is a prominent provider of software solutions for supply chain management, inventory optimization, and omnichannel commerce. Three of Manhattan’s solutions include Omnichannel Commerce, Supply Chain Execution, and Supply Chain Planning. Omnichannel Commerce aids companies in establishing seamless connections across various sales channels for better customer experiences.

The Financial Duel: Manhattan Associates Vs. Tesla

Manhattan Associates, a leading provider of supply chain and omnichannel solutions, has been riding the wave of success. With robust revenue growth of over 21% in 2023, the company showcases a splendid performance. Amidst the market’s turbulence, Manhattan Associates has managed to maintain its financial superiority, receiving a significant boost from the COVID-19 pandemic. The company’s trio of solutions – Distributed Order Management, Supply Chain Execution, and Retail Store Operations – has consistently propelled its success story. These solutions, especially the Supply Chain Execution tool, have helped companies streamline their operations, fostering efficient decision-making.

Manhattan Associates’ Financial Performance

Despite this commendable progress, investors are beginning to exhibit some caution. Manhattan Associates’ shares, which surged a striking 77% in 2023, are currently trading at 65.3x forward earnings. This soaring valuation has stirred apprehension among investors, hinting at a potential market correction. While the company’s management maintains optimism, investors remain wary of the possibility of a sharp market reversal causing their shares to plummet.

Tesla’s Triumph and Trials

Source: Arina P Habich / Shutterstock.com

Tesla, on the other hand, has been a fascinating spectacle in the global electric vehicle market. The company’s audacity in defying skeptics and breaking records throughout 2023 has intrigued industry observers. Despite a formidable show in quarterly earnings, Tesla seems to be walking a tightrope. The strategic price cuts, aiming to ramp up deliveries while exerting pressure on gross margins, pose challenges. Elon Musk’s sobering guidance, citing interest rates and faltering consumer demand, has further clouded the company’s outlook. Notably, Elon Musk’s prophecy gains credence from China’s BYD, which outpaced Tesla as China’s leading EV seller in 2023, hinting at a brewing rivalry.

Investors’ Dilemma

As investors grapple with the investment conundrum, they are confronted by high valuations. Tesla’s shares, trading at 60.5x forward earnings, appear to carry a significant downside risk, steering investors towards a probable sell-off. The mounting pressure from emerging competitors and economic headwinds underscores the delicate equilibrium that Tesla treads. The juxtaposition of the soaring valuations and the impending challenges has cast a pall over the once-gleaming prospects of the EV giant.

On the date of publication, Tyrik Torres did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.